TITLE

ORTHOVITA SELLS BIOGRAN DENTAL LINE TO IMPLANT INNOVATIONS

PUB. DATE
May 2000
SOURCE
Biotech Equipment Update;May2000, p5
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
Focuses on issues related to Orthovita Inc. in Malvern, Pennsylvania. Sale of Biogran dental grafting product line to Implant Innovations Inc.; Use of sale proceeds to enhance working capital for the commercialization of CORTOSS and VITOSS products; Reason for increase in 1999 net losses of Orthovita; Issuance of patents for synthetic bone substitute technology platforms.
ACCESSION #
3011120

 

Related Articles

  • Stryker reports that it will acquire Orthovita for $316M. FORD, OMAR // Medical Device Daily;5/17/2011, Vol. 15 Issue 95, p1 

    The article reports on the acquisition of Orthovita by Stryker. Located in Kalamazoo, Michigan, Stryker, a provider of orthopedic services, plans to merge with Orthovita, in order for it to expand its orthobiological supplies and become more competitive in the field of Spine, Orthopedics, and...

  • ORTHOVITA GETS NANO-PARTICLE STRUCTURED TECHNOLOGY PATENT.  // Worldwide Biotech;Mar2002, Vol. 14 Issue 3, p6 

    Reports on the patent received by Orthovita Inc. on its nano-structured technology

  • ORTHOVITA'S CORTOSS SYNTHETIC BONE FILLER MORE EFFECTIVE.  // Worldwide Biotech;Mar2003, Vol. 15 Issue 3, p3 

    Focuses on clinical studies which examined the efficacy of CORTOSS Synthetic Cortical Bone Void Filler, a biomaterial designed to replace and reinforce bone in the spine weakened by osteoporosis and metastatic disease, from Orthovita Inc.

  • ORTHOVITA COMPLETES RHAKOSS PILOT CLINICAL STUDY IN EUROPE.  // Worldwide Biotech;Oct2002, Vol. 14 Issue 10, p2 

    Reports that Orthovita Inc. has completed the initial clinical pilot study in Europe for RHAKOSS Synthetic Bone Spinal Implant.

  • Stockholders aim to block Stryker, Orthovita merger.  // Medical Device Daily;6/2/2011, Vol. 15 Issue 106, p3 

    The article reports on the plan of Orthovita stockholders to stop the 316 million U.S. dollars merger of the company with Stryker, which according to a lawsuit filed by the shareholders breaches the fiduciary duty of Orthovita.

  • AAOS notebook.  // Medical Device Daily;2/18/2011, Vol. 15 Issue 34, p2 

    The article reports that orthologics and biosurgery company Orthovita will launch Vitoss Bioactive Foam-2X Bone Graft Substitute, a non-structural bone void filler for use in the pelvis, extremities and posterolateral spine.

  • Styker completes $316M acquisition of Orthovita.  // Medical Device Daily;6/30/2011, Vol. 15 Issue 121, p2 

    The article announces the acquisition of Orthovita based in Pennsylvania by Michigan-based orthopedic device-maker Stryker.

  • UPDATE: Stryker Acquires Orthovita. Cody, Tamika // Mergers & Acquisitions Report;5/23/2011, Vol. 24 Issue 21, p23 

    The article deals with the acquisition of the common stocks owned by U.S. orthobiologics platform developer Orthovita by medical equipment and device developer Stryker Corp. in May 2011.

  • Angiotech: In No Hurry To Take Out Orthovita. Cohen, Judy Radler // Mergers & Acquisitions Report;6/20/2005, Vol. 18 Issue 24, p1 

    Reports on the decision of U.S. firm Angiotech Pharmaceuticals Inc. to delay its plan of acquiring Orthovita Inc. following the rejection of its offer by Orthovita Inc. Cash offer made by Angiotech Pharmaceuticals Inc.; Analysis of the merger and acquisition tactics of Angiotech...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics